CVS Health Aktie
42,68
EUR
-1,33
EUR
-3,01
%
43,75
USD
-0,04
USD
-0,09
%
nachbörslich
CVS Health Aktie Analyse
| 05.06.19 | CVS Health Buy | Standpoint Research | |
| 12.04.19 | CVS Health Market Perform | BMO Capital Markets | |
| 18.12.18 | CVS Health overweight | Barclays Capital | |
| 30.01.18 | CVS Health Strong Buy | Needham & Company, LLC | |
| 02.01.18 | CVS Health Buy | Needham & Company, LLC | |
| 04.12.17 | CVS Health Buy | Deutsche Bank AG | |
| 04.12.17 | CVS Health Buy | Needham & Company, LLC | |
| 10.11.17 | CVS Health Buy | Needham & Company, LLC | |
|
Werbung
|
|||
| 19.09.17 | CVS Health Outperform | RBC Capital Markets | |
| 28.04.17 | CVS Health Buy | Tigress Financial | |
| 09.11.16 | CVS Health Buy | Mizuho | |
| 23.06.16 | CVS Health Buy | Mizuho | |
| 04.05.16 | CVS Health Outperform | RBC Capital Markets | |
| 04.05.16 | CVS Health Buy | Mizuho | |
| 10.03.16 | CVS Health overweight | Barclays Capital | |
| 22.01.16 | CVS Health Outperform | Robert W. Baird & Co. Incorporated | |
| 18.12.15 | CVS Health overweight | Barclays Capital | |
| 17.12.15 | CVS Health Outperform | Oppenheimer & Co. Inc. | |
| 28.08.15 | CVS Health Outperform | Oppenheimer & Co. Inc. | |
| 10.08.15 | CVS Health Buy | Argus Research Company | |
| 05.08.15 | CVS Health Outperform | RBC Capital Markets | |
| 18.06.15 | CVS Health Outperform | Oppenheimer & Co. Inc. | |
| 11.02.15 | CVS Health Buy | Argus Research Company | |
| 11.02.15 | CVS Health Outperform | RBC Capital Markets | |
| 11.02.15 | CVS Health Buy | Mizuho | |
| 18.12.14 | CVS Health Buy | Argus Research Company | |
| 17.12.14 | CVS Health Outperform | RBC Capital Markets | |
| 12.11.14 | CVS Health Buy | Mizuho | |
| 05.11.14 | CVS Health Buy | Argus Research Company | |
| 05.11.14 | CVS Health Outperform | RBC Capital Markets | |
| 17.12.12 | CVS Health outperform | RBC Capital Markets | |
| 14.12.12 | CVS Health buy | UBS AG | |
| 11.12.12 | CVS Health buy | UBS AG | |
| 07.11.12 | CVS Health buy | UBS AG | |
| 28.05.12 | CVS Health overweight | Barclays Capital | |
| 03.05.12 | CVS Health buy | UBS AG | |
| 27.04.12 | CVS Health overweight | Barclays Capital | |
| 10.02.12 | CVS Health overweight | Barclays Capital | |
| 09.02.12 | CVS Health outperform | RBC Capital Markets | |
| 02.02.12 | CVS Health overweight | Barclays Capital | |
| 22.12.11 | CVS Health overweight | Barclays Capital | |
| 07.11.11 | CVS Health outperform | RBC Capital Markets | |
| 07.11.11 | CVS Health overweight | Barclays Capital | |
| 02.11.11 | CVS Health overweight | Barclays Capital | |
| 08.08.11 | CVS Health overweight | Barclays Capital | |
| 09.05.11 | CVS Health overweight | Barclays Capital | |
| 09.05.11 | CVS Health outperform | Credit Suisse Group | |
| 13.04.11 | CVS Health overweight | Barclays Capital | |
| 07.02.11 | CVS Health overweight | Barclays Capital | |
| 14.06.10 | CVS Health kaufen | Caris & Company, Inc. | |